Evidence map›Paper›PMID 30140704›Full record

ArticleBioMed research international2018

The Evaluation of Proanthocyanidins/Chitosan/Lecithin Microspheres as Sustained Drug Delivery System.

Hong-Li Yu, Zhan-Qin Feng, Jing-Jing Zhang, Yong-Hong Wang, De-Jun Ding, Yuan-Yuan Gao, Wei-Fen Zhang

Abstract read
In one paragraph

Article in BioMed research international, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hong-Li YuCollege of Pharmacy, Weifang Medical University, Weifang 261053, Shandong, China.
Zhan-Qin FengWeifang Maternity and Child Care Hospital, Weifang 261053, Shandong, China.
Jing-Jing ZhangCollege of Basic Medical, Qingdao Binhai University, Qingdao 266555, Shandong, China.
Yong-Hong WangCollege of Pharmacy, Weifang Medical University, Weifang 261053, Shandong, China.
De-Jun DingCollege of Pharmacy, Weifang Medical University, Weifang 261053, Shandong, China.
Yuan-Yuan GaoCollege of Pharmacy, Weifang Medical University, Weifang 261053, Shandong, China.
Wei-Fen ZhangCollege of Pharmacy, Weifang Medical University, Weifang 261053, Shandong, China.ORCID 0000-0002-3220-525X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Proanthocyanidin (PC) has attracted wide attention on cosmetics and pharmaceutical due to its antioxidant, anticancer, antimicrobial, antiangiogenic, and anti-inflammatory activities. However, PC applications are limited because of its sensitivity to thermal treatment, light, and oxidation and the poor absorption in the gastrointestinal tract. Thus, a novel dosage form of PC needs to be designed to improve its stability and bioavailability for drug delivery. The objective of this study is to fabricate proanthocyanidins/chitosan/lecithin (PC/CTS/LEC) microspheres and investigate various characteristics. In the current study, PC/CTS/LEC microspheres were prepared by spray-drying technology. The yield (61.68%), encapsulation efficiency (68.19%), and drug loading capacity (17.05%) were found in the results. The scanning electron microscope demonstrated that the microspheres were spherical in shape with wrinkled surfaces. DSC study displayed that the microspheres stability was greatly improved when comparing with bare PC. The in vitro release study showed that the 76.92% of PC was released from microspheres within 48 h. The moisture contents of microspheres ranged from 8% to 13%. The swelling rate and tapped density of microspheres were elevated with increasing the concentration of chitosan in the formulations. The moisture uptake of microspheres was saturated at 40°C/RH75% within 12 h. Our results indicated that the stability of PC/CTS/LEC microspheres was enhanced, and it is a promising carrier for sustained drug delivery system.

Indexed as

ChitosanDrug Delivery SystemsLecithinsMicrospheresProanthocyanidinsDrug CarriersMicroscopy, Electron, ScanningParticle SizeChitosanDrug CarriersLecithinsProanthocyanidins

Identifiers

PMID30140704
PMCPMC6081580

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.